Skip to content

Effectiveness of Two Regimens of Misoprostol Alone for Early Pregnancy Termination and Use of SQPT for At-Home Follow-Up

Assessing the Effectiveness of Two Regimens of Misoprostol Alone for Early Pregnancy Termination and Use of a Semi-Quantitative Pregnancy Test for At-Home Follow-Up

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02299401
Enrollment
401
Registered
2014-11-24
Start date
2014-12-31
Completion date
2016-10-31
Last updated
2016-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

Medical abortion, Induced abortion, Pregnancy test, Semi-quantitative pregnancy test

Brief summary

This randomized trial will compare the rates of ongoing pregnancy, safety/side effects and acceptability of two medical abortion regimens that are commonly used in Latin America. The first regimen will involve three 800 mcg doses of misoprostol taken buccally in three hour intervals; the second will involve three 800 mcg doses of misoprostol taken sublingually in three hour intervals. This study will also aim to assess the feasibility and acceptability of a semi-quantitative pregnancy test (SQPT) for at-home follow-up in both settings.

Interventions

DRUGMisoprostol

Women will receive three 800 mcg doses of misoprostol.

All women will be given a semi-quantitative pregnancy test (SQPT) for at-home follow-up.

Sponsors

Gynuity Health Projects
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Presents for voluntary termination of pregnancy * Gestational age ≤ 70 days by last menstrual period plus clinical assessment or ultrasound * General good health including the absence of conditions which contraindicate the use of misoprostol for pregnancy termination * Agrees to return for follow-up visit and willing to provide an address and/or telephone number for the purposes of follow-up * Able to consent to study participation

Exclusion criteria

* Gestational age \> 70 days last menstrual period * Confirmed or suspected ectopic or molar pregnancy * Contraindications to medical abortion include having an intrauterine device in place and history of allergy to misoprostol or other prostaglandins

Design outcomes

Primary

MeasureTime frameDescription
Ongoing pregnancy rates1-2 weeksThe study will assess and compare the rates of ongoing pregnancy for the two medical abortion regimens at 1-2 week follow up.

Secondary

MeasureTime frameDescription
Incidence of side effects and complications as a measure of safety/ side effects1-2 weeksAssess and compare the safety/side effects of two regimens of misoprostol alone for early pregnancy termination.
Reported acceptability and satisfaction with misoprostol regimen1-2 weeksThe study will also assess and compare satisfaction and acceptability of each medical abortion regimen as rated by the women.
Usability of SQPT as measured by women's ability to assess success of medical abortion procedure at home1-2 weeksThe study will assess women's ability to use the SQPT effectively for at-home assessment of the success of the medical abortion procedure.
Self-reported acceptability and satisfaction with SQPT as a means of at-home follow up1-2 weeksThe study will also assess the acceptability of the test as a means for at-home follow-up after medical abortion as rated by the women. The woman will answer questions about whether she found the SQPT easy to use an acceptable for at-home follow up.

Countries

Bolivia, Ecuador

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026